Core Laboratories’ Earnings Mixed; Shares Indicated Lower (CLB)
Core Laboratories NV (NYSE: CLB) reports Q2 EPS $0.71 vs consensus of $0.72. Core Laboratories NV reports Q2 revenue $198.9 million vs consensus of $189.52 million.
The company said that they see Q3 EPS of $0.76 to $0.78. This compares to the Street consensus of $0.76 per share on revenue of 197.11 million.
Shares of CLB are bid lower in the after-hours.
Core Laboratories N.V. is a provider of reservoir description, production enhancement and reservoir management services to the oil and gas industry. The company operates in three business segments: reservoir description, production enhancement and reservoir management.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.